Finance

Beta
Lists
Q2 2026 earnings • released • EPS met 0.00%
See results
SVA:TSE
Sernova Biotherapeutics Inc
CA$0.14
-6.45%
(-0.010) 1D
Jun 12, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
CA$0.16
High
CA$0.16
Low
CA$0.14
Mkt. cap
53.14M
Avg. vol.
117.22K
Volume
129.33K
52-wk high
CA$0.21
52-wk low
CA$0.12
EPS
-CA$0.04
Beta
30.45
Shares outstanding
347.73M
No. of employees
8
Open
CA$0.16
High
CA$0.16
Low
CA$0.14
Mkt. cap
53.14M
Avg. vol.
117.22K
Volume
129.33K
52-wk high
CA$0.21
52-wk low
CA$0.12
EPS
-CA$0.04
Beta
30.45
Shares outstanding
347.73M
No. of employees
8
News stories
From sources across the web
Wealth Awesome
Wealth Awesome
·
21 hours ago
Why Sernova Corp stock is plummeting today
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersLondon, Ontario, Canada
SectorBiotechnology
Websitesernova.com
Last report
Jun 11, 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
-CA$0.01 / -CA$0.01
0.00%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.74M
809.63K
434.15K
444.87K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.76M
1.59M
1.68M
-
Operating expense
3.50M
2.40M
2.12M
2.30M
Total operating expenses
3.50M
2.40M
2.12M
-
Operating income
-3.50M
-2.40M
-2.12M
-
Other non operating income
-
-
-
-
EBT including unusual items
-4.05M
-2.25M
-2.41M
-3.23M
EBT excluding unusual items
-4.10M
-2.26M
-2.41M
-
Income tax expense
21.12K
-54.97K
-72.00K
-
Effective tax rate
-0.52%
2.44%
2.99%
-
Other operating expenses
-
-
-
-
Net income
-4.07M
-2.20M
-2.33M
-
Net profit margin
-
-
-
-
Earnings per share
-0.01
-0.01
-0.01
-0.01
Interest and investment income
131.00
260.60K
-
413.00
Interest expense
-541.68K
-
-477.12K
-920.95K
Net interest expenses
-541.54K
260.60K
-477.12K
-920.53K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.40M
-2.34M
-2.11M
-2.29M
Gain or loss from assets sale
-50.96K
-4.25K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer